Pharmaceutical formulation comprising pyrazolo[4,3-d] pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists

Details for Australian Patent Application No. 2002235832 (hide)

Owner MERCK PATENT GMBH

Inventors Eggenweiler, Hans-Michael; Eiermann, Volker; Schelling, Pierre

Agent Davies Collison Cave

Pub. Number AU-A-2002235832

PCT Pub. Number WO2002/062343

Priority 101 04 800.9 02.02.01 DE; 101 04 801.7 02.02.01 DE; 101 04 802.5 02.02.01 DE

Filing date 14 January 2002

Wipo publication date 19 August 2002

International Classifications

A61K 031/505 - Pyrimidines

A61P 025/22 Drugs for disorders of the nervous system

A61K 031/27

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002235832

24 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002235833-PROTECTIVE COATING HAVING A BI-LAYER COATING STRUCTURE

2002235831-SILANYL PHENOLS AND NAPHTHOLS